Holen Sie sich die Stockscreener-App
69.97
0.55%
-0.41
Schlusskurs vom Vortag:
$70.38
Offen:
$70.24
24-Stunden-Volumen:
18,906
Relative Volume:
0.16
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.07%
1M Leistung:
-0.75%
6M Leistung:
+26.89%
1J Leistung:
+46.82%
1-Tages-Spanne:
$69.95
$70.53
1-Wochen-Bereich:
$69.85
$71.77
52-Wochen-Spanne:
$45.80
$74.34
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
State Street Spdr S P Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
69.97 | 229.97M | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
376.37 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
763.43 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
767.05 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
296.02 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
717.41 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
Ditch These Historic ETF September Underperformers - Finviz
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense - Barron's
SPDR Series TrustState Street SPDR S&P Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
ETFs Investing in Ligand Pharmaceuticals Incorporated Stocks - TradingView
State Street SPDR S&P/ASX 200 Listed Property ETF Reports Daily NAV Update for September 2, 2026 - Kalkine Media
State Street SPDR S&P/ASX 200 ETF Announces Daily NAV and Fund Update for September 1, 2026 - Kalkine Media
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - Eastern Progress
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
Healthcare ETFs Are Looking Up: Here's Why - TradingView
ETFs Investing in Jazz Pharmaceuticals Public Limited Company Stocks - TradingView
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
XPH vs PJP: Which Pharma ETF Offers Better Value - The Motley Fool
ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks - TradingView
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPH - The Motley Fool
ETFs Investing in Viatris, Inc. Stocks - TradingView
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Is State Street SPDR S&P Telecom ETF (XTL) a Strong ETF Right Now? - Yahoo Finance
8 ETF Winners in the ‘Pay Me Now’ Trade - Barron's
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
ANI Pharmaceuticals Inc (ANIP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Royalty Pharma PLC (RPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Perrigo Company PLC (PRGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Innoviva Inc (INVA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
EyePoint Pharmaceuticals Inc (EYPT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harmony Biosciences Holdings Inc (HRMY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enliven Therapeutics Inc (ELVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Harrow Inc (HROW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Liquidia Corp (LQDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Supernus Pharmaceuticals Inc (SUPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Amphastar Pharmaceuticals Inc (AMPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvation Bio Inc (NUVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nektar Therapeutics (NKTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
State Street SPDR S&P/ASX 200 ETF Posts $6.6 Billion Fund Value with 83.2 Million Units Outstanding - Kalkine
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collegium Pharmaceutical Inc (COLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENZ Therapeutics Inc (LENZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phathom Pharmaceuticals Inc (PHAT) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Finanzdaten der State Street Spdr S P Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für State Street Spdr S P Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.32%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):